Pfizer, BioNTech Say Vaccine Is Secure for Younger Youngsters

Pfizer Inc. and accomplice BioNTech SE mentioned their Covid-19 vaccine was discovered to be secure in youngsters ages 5 to 11 years in a late-stage research and generated a robust immune response in them, bringing the prospect of broader vaccination protection nearer.

Pfizer mentioned it might share the outcomes with regulators within the U.S. and different international locations and search emergency use authorization within the U.S. as early as the tip of the month.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.